Download Docs
Export

EPITAC

98424138 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Feb. 27, 2024
Serial No. 98424138
Examining Attorney KAELIE ELIZABETH KUNG
Class Pharmaceutical preparations for the treatment and prevention of oncogenic and autoimmune diseases signals using protein degradation in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, pulmonology, pneumology, oncology, metabolism, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation using protein degradation for use in treating oncology indications, namely, non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), gastrointestinal stromal tumor (GIST), Gastric, Muscle invasive bladder cancer (MIBC), Colorectal Carcinoma (CRC), and autoimmune disease, namely, Pemphigus Vulgaris, Myasthenia Gravis, Rheumatoid arthritis, and Lupus; pharmaceutical preparations for the treatment of infectious diseases, immunodeficiency diseases, metabolic disease, Urticaria, Mastocytosis, Asthma, Alzheimer’s disease, Parkinson’s Disease, Multiple sclerosis, non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), gastrointestinal stromal tumor (GIST), Gastric, Muscle invasive bladder cancer (MIBC), Colorectal Carcinoma (CRC), and autoimmune disease, namely, Pemphigus Vulgaris, Myasthenia Gravis, Rheumatoid arthritis, and Lupus; pharmaceutical preparations, namely, targeted therapies that degrade disease driving membrane and extracellular proteins to treat oncology and autoimmune disease, namely, metabolic disease, Urticaria, Mastocytosis, Asthma, Alzheimer’s disease, Parkinson’s Disease, Multiple sclerosis, non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), gastrointestinal stromal tumor (GIST), Gastric, Muscle invasive bladder cancer (MIBC), Colorectal Carcinoma (CRC), and autoimmune disease, namely, Pemphigus Vulgaris, Myasthenia Gravis, Rheumatoid arthritis, and Lupus; 005; 006; 018; 044; 046; 051; 052; 100; 101
EPITAC
Case Type Trademark Service mark
Status A third request for extension of time to file a Statement of Use has been granted.
Last Updated: 1 day, 6 hours ago
Filing Date # Docket Text